Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types

Clinical trial NCT03012581 · COMPLETED

Trial details

NCT number: NCT03012581
Sponsor: UNICANCER
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell Head and Neck Neoplasm Skin Neoplasms Microsatellite Instability Penile Neoplasms Cancer With POLE Exonucleasic Domain Mutation

Start date: 2017-06-16
Primary completion: 2022-12-22
Enrollment: 269

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.